Investors

Investors

Corporate Profile

Horizon is a biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.

Horizon's global headquarters is in Dublin, Ireland and its U.S. headquarters is in Deerfield, Ill.  The Company also has offices in Chicago, Ill.; South San Francisco, Calif.; Washington, D.C.; Gaithersburg, Md.; Rockville, Md.; Mannheim, Germany and a growing presence in Japan.

Upcoming Events

Stock Quote

Volume: